Wholly Owned Subsidiary of Alion Science and Technology, says Solution will also Help Decrease Insurance Denials and Increase Accuracy of Patient Data
Large numbers of health providers have inefficient processes that often lead to lost and delayed revenue. WCI’s Revenue Cycle Management solution, a set of components built on EMC’s Documentum xCP Content Management platform, features improvements that will ultimately streamline revenue cycle processes from patient admission through claims payment, decrease the number of insurance denials and improve access to relevant content.
The Patient Access Services components will speed admissions, increasing accuracy of patient information, and jump-start the Revenue Cycle process. Second, the Encounter Management components will integrate the Electronic Health Record (EHR) into the Revenue Cycle to accurately capture services. And finally, the
“This is a win-win solution for everyone—healthcare providers can gain an increase in approved claims and revenue and patients may endure less paperwork and fewer healthcare denials,” said
Brennan added that WCI selected EMC’s Documentum xCP Content Management platform for this particular solution set to make use of its strong business process management and security features and the ability to centrally manage content. “Our customers depend on us to identify and apply the right technologies to increase efficiency and control costs,” he explained.
The Revenue Cycle Management solution launch coincides with the
WCI has been helping commercial, non-profit and federal clients oversee and implement complex business technology solutions since 2003. WCI’s recent efforts have been working with organizations, such as the
About Alion Science and Technology
Alion Science and Technology is an employee-owned technology solutions company delivering technical expertise and operational support to the
This press release contains information about management’s view of Alion’s future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of a variety of risk factors and uncertainties discussed in documents periodically filed by Alion with the
Alion Science and Technology
Source: Alion Science and Technology